Acted as a Rule 3 Adviser, Financial Adviser and Broker to Diurnal Group PLC

    News Read

Panmure Gordon was delighted to act as a Rule 3 Adviser, Financial Adviser and Broker to Diurnal Group PLC for the recommended cash acquisition by Neurocrine Biosciences for c.£48m.

Panmure Gordon’s team included: Freddy Crossley, Emma Earl, Rupert Dearden and Mark Rogers.

Freddy Crossley

Managing Director, Head of Healthcare

Emma Earl

Managing Director, Healthcare, Investment Banking

Rupert Dearden

Managing Director, Corporate Broking Services

Other insights like this

View all